AlphaMark Advisors’s Yarrow Bioscience YARW Stock Holding History

AlphaMark Advisors’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2	Closed	-$10K	–	569
2020 Q2	$10K	Buy	2 +1	+100%	+$6.77K	﹤0.01%	369
2020 Q1	$5K	Buy	+1	New	+$15.7K	﹤0.01%	389

Other funds holding YARW

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

AlphaMark Advisors's YARW Position: Q3 2020 in Review

AlphaMark Advisors sold out of Yarrow Bioscience (YARW) in Q3 2020, closing a stake of 2 shares — an estimated $10K sold.

AlphaMark Advisors first reported a position in YARW in Q1 2020 and held it in 2 quarters. The position peaked at $10K in Q2 2020. 97 funds tracked by Wall St. Rank hold YARW as of Q3 2020.

AlphaMark Advisors reported no remaining Yarrow Bioscience position as of Q3 2020 after selling out during the quarter.
AlphaMark Advisors sold 2 Yarrow Bioscience shares in Q3 2020, an estimated $10K.
AlphaMark Advisors first reported a position in Yarrow Bioscience in Q1 2020 and held it in 2 quarters.
AlphaMark Advisors's Yarrow Bioscience position peaked at $10K in Q2 2020.
97 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2020.

Based on AlphaMark Advisors's 13F filing for Q3 2020, filed 6 Nov 2020.